| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| TFX - Teleflex Incorporated | SELL | -75 @ 132.75 | -9,956 | The ETF sold 75 shares of TFX on 2025-02-28. The shares were previously bought for an average price of 187.041. The Teleflex Incorporated shares were sold for -29.0% lower than average price of previous purchases. This resulted in an overall loss of 4,072 The average price that the ETF previously sold TFX share for is so the ETF has sold 75 shares on 2025-02-28 at a higher price than the previous selling average. |
| DVA - DaVita HealthCare Partners Inc | SELL | -75 @ USD 147.88 | USD -11,091 | The ETF sold 75 shares of DVA on 2025-02-28. The shares were previously bought for an average price of USD 158.416. The DaVita HealthCare Partners Inc shares were sold for -6.7% lower than average price of previous purchases. This resulted in an overall loss of USD 790 The average price that the ETF previously sold DVA share for is USD so the ETF has sold 75 shares on 2025-02-28 at a higher price than the previous selling average. |
| CRL - Creightons Plc | SELL | -81 @ USD 165.31 | USD -13,390 | The ETF sold 81 shares of CRL on 2025-02-28. The shares were previously bought for an average price of USD 176.556. The Creightons Plc shares were sold for -6.4% lower than average price of previous purchases. This resulted in an overall loss of USD 911 The average price that the ETF previously sold CRL share for is USD so the ETF has sold 81 shares on 2025-02-28 at a higher price than the previous selling average. |
| HSIC - Henry Schein Inc | SELL | -207 @ USD 72.17 | USD -14,939 | The ETF sold 207 shares of HSIC on 2025-02-28. The shares were previously bought for an average price of USD 74.8459. The Henry Schein Inc shares were sold for -3.6% lower than average price of previous purchases. This resulted in an overall loss of USD 554 The average price that the ETF previously sold HSIC share for is USD so the ETF has sold 207 shares on 2025-02-28 at a higher price than the previous selling average. |
| TECH - Bio-Techne Corp | SELL | -261 @ USD 61.75 | USD -16,117 | The ETF sold 261 shares of TECH on 2025-02-28. The shares were previously bought for an average price of USD 69.761. The Bio-Techne Corp shares were sold for -11.5% lower than average price of previous purchases. This resulted in an overall loss of USD 2,091 The average price that the ETF previously sold TECH share for is USD so the ETF has sold 261 shares on 2025-02-28 at a higher price than the previous selling average. |
| UHS - Universal Health Services Inc | SELL | -93 @ USD 175.25 | USD -16,298 | The ETF sold 93 shares of UHS on 2025-02-28. The shares were previously bought for an average price of USD 193.322. The Universal Health Services Inc shares were sold for -9.3% lower than average price of previous purchases. This resulted in an overall loss of USD 1,681 The average price that the ETF previously sold UHS share for is USD so the ETF has sold 93 shares on 2025-02-28 at a higher price than the previous selling average. |
| MRNA - Moderna Inc | SELL | -555 @ USD 30.96 | USD -17,183 | The ETF sold 555 shares of MRNA on 2025-02-28. The shares were previously bought for an average price of USD 38.5445. The Moderna Inc shares were sold for -19.7% lower than average price of previous purchases. This resulted in an overall loss of USD 4,209 The average price that the ETF previously sold MRNA share for is USD so the ETF has sold 555 shares on 2025-02-28 at a higher price than the previous selling average. |
| VTRS - Viatris Inc | SELL | -1,935 @ USD 9.23 | USD -17,860 | The ETF sold 1935 shares of VTRS on 2025-02-28. The shares were previously bought for an average price of USD 11.7218. The Viatris Inc shares were sold for -21.3% lower than average price of previous purchases. This resulted in an overall loss of USD 4,822 The average price that the ETF previously sold VTRS share for is USD so the ETF has sold 1935 shares on 2025-02-28 at a higher price than the previous selling average. |
| SOLV - Solventum Corp. | SELL | -225 @ USD 79.75 | USD -17,944 | The ETF sold 225 shares of SOLV on 2025-02-28. The shares were previously bought for an average price of USD 74.572. The Solventum Corp. shares were sold for 6.9% higher than average price of previous purchases. This sale made a profit of USD 1,165 The average price that the ETF previously sold SOLV share for is USD so the ETF has sold 225 shares on 2025-02-28 at a higher price than the previous selling average. |
| INCY - Incyte Corporation | SELL | -258 @ USD 73.5 | USD -18,963 | The ETF sold 258 shares of INCY on 2025-02-28. The shares were previously bought for an average price of USD 73.6831. The Incyte Corporation shares were sold for -0.2% lower than average price of previous purchases. This resulted in an overall loss of USD 47 The average price that the ETF previously sold INCY share for is USD so the ETF has sold 258 shares on 2025-02-28 at a higher price than the previous selling average. |
| ALGN - Align Technology Inc | SELL | -111 @ USD 187.03 | USD -20,760 | The ETF sold 111 shares of ALGN on 2025-02-28. The shares were previously bought for an average price of USD 211.197. The Align Technology Inc shares were sold for -11.4% lower than average price of previous purchases. This resulted in an overall loss of USD 2,683 The average price that the ETF previously sold ALGN share for is USD so the ETF has sold 111 shares on 2025-02-28 at a higher price than the previous selling average. |
| RVTY - Revvity Inc. | SELL | -198 @ USD 112.15 | USD -22,206 | The ETF sold 198 shares of RVTY on 2025-02-28. The shares were previously bought for an average price of USD 117.164. The Revvity Inc. shares were sold for -4.3% lower than average price of previous purchases. This resulted in an overall loss of USD 993 The average price that the ETF previously sold RVTY share for is USD so the ETF has sold 198 shares on 2025-02-28 at a higher price than the previous selling average. |
| HOLX - Hologic Inc | SELL | -378 @ USD 63.39 | USD -23,961 | The ETF sold 378 shares of HOLX on 2025-02-28. The shares were previously bought for an average price of USD 71.4801. The Hologic Inc shares were sold for -11.3% lower than average price of previous purchases. This resulted in an overall loss of USD 3,058 The average price that the ETF previously sold HOLX share for is USD so the ETF has sold 378 shares on 2025-02-28 at a higher price than the previous selling average. |
| WST - West Pharmaceutical Services Inc | SELL | -117 @ USD 232.34 | USD -27,184 | The ETF sold 117 shares of WST on 2025-02-28. The shares were previously bought for an average price of USD 278.546. The West Pharmaceutical Services Inc shares were sold for -16.6% lower than average price of previous purchases. This resulted in an overall loss of USD 5,406 The average price that the ETF previously sold WST share for is USD so the ETF has sold 117 shares on 2025-02-28 at a higher price than the previous selling average. |
| MOH - MOH | SELL | -93 @ USD 301.12 | USD -28,004 | The ETF sold 93 shares of MOH on 2025-02-28. The shares were previously bought for an average price of USD 303.801. The MOH shares were sold for -0.9% lower than average price of previous purchases. This resulted in an overall loss of USD 249 The average price that the ETF previously sold MOH share for is USD so the ETF has sold 93 shares on 2025-02-28 at a higher price than the previous selling average. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | SELL | -93 @ USD 301.12 | USD -28,004 | The ETF sold 93 shares of MOH on 2025-02-28. The shares were previously bought for an average price of USD 303.801. The LVMH Moët Hennessy - Louis Vuitton Société Européenne shares were sold for -0.9% lower than average price of previous purchases. This resulted in an overall loss of USD 249 The average price that the ETF previously sold MOH share for is USD so the ETF has sold 93 shares on 2025-02-28 at a higher price than the previous selling average. |
| BAX - Baxter International Inc | SELL | -843 @ USD 34.51 | USD -29,092 | The ETF sold 843 shares of BAX on 2025-02-28. The shares were previously bought for an average price of USD 33.4331. The Baxter International Inc shares were sold for 3.2% higher than average price of previous purchases. This sale made a profit of USD 908 The average price that the ETF previously sold BAX share for is USD so the ETF has sold 843 shares on 2025-02-28 at a higher price than the previous selling average. |
| COO - The Cooper Companies, Inc. Common Stock | SELL | -327 @ USD 90.38 | USD -29,554 | The ETF sold 327 shares of COO on 2025-02-28. The shares were previously bought for an average price of USD 95.8273. The The Cooper Companies, Inc. Common Stock shares were sold for -5.7% lower than average price of previous purchases. This resulted in an overall loss of USD 1,781 The average price that the ETF previously sold COO share for is USD so the ETF has sold 327 shares on 2025-02-28 at a higher price than the previous selling average. |
| PODD - Insulet Corporation | SELL | -114 @ USD 272.27 | USD -31,039 | The ETF sold 114 shares of PODD on 2025-02-28. The shares were previously bought for an average price of USD 271.308. The Insulet Corporation shares were sold for 0.4% higher than average price of previous purchases. This sale made a profit of USD 110 The average price that the ETF previously sold PODD share for is USD so the ETF has sold 114 shares on 2025-02-28 at a higher price than the previous selling average. |
| DGX - Quest Diagnostics Incorporated | SELL | -183 @ USD 172.9 | USD -31,641 | The ETF sold 183 shares of DGX on 2025-02-28. The shares were previously bought for an average price of USD 164.656. The Quest Diagnostics Incorporated shares were sold for 5.0% higher than average price of previous purchases. This sale made a profit of USD 1,509 The average price that the ETF previously sold DGX share for is USD so the ETF has sold 183 shares on 2025-02-28 at a higher price than the previous selling average. |
| BIIB - Biogen Inc | SELL | -240 @ USD 140.5 | USD -33,720 | The ETF sold 240 shares of BIIB on 2025-02-28. The shares were previously bought for an average price of USD 151.719. The Biogen Inc shares were sold for -7.4% lower than average price of previous purchases. This resulted in an overall loss of USD 2,693 The average price that the ETF previously sold BIIB share for is USD so the ETF has sold 240 shares on 2025-02-28 at a higher price than the previous selling average. |
| LH - Laboratory Corporation of America Holdings | SELL | -135 @ USD 251.04 | USD -33,890 | The ETF sold 135 shares of LH on 2025-02-28. The shares were previously bought for an average price of USD 244.192. The Laboratory Corporation of America Holdings shares were sold for 2.8% higher than average price of previous purchases. This sale made a profit of USD 924 The average price that the ETF previously sold LH share for is USD so the ETF has sold 135 shares on 2025-02-28 at a higher price than the previous selling average. |
| ZBH - Zimmer Biomet Holdings Inc | SELL | -327 @ USD 104.32 | USD -34,113 | The ETF sold 327 shares of ZBH on 2025-02-28. The shares were previously bought for an average price of USD 106.745. The Zimmer Biomet Holdings Inc shares were sold for -2.3% lower than average price of previous purchases. This resulted in an overall loss of USD 793 The average price that the ETF previously sold ZBH share for is USD so the ETF has sold 327 shares on 2025-02-28 at a higher price than the previous selling average. |
| STE - STERIS plc | SELL | -162 @ USD 219.26 | USD -35,520 | The ETF sold 162 shares of STE on 2025-02-28. The shares were previously bought for an average price of USD 220.307. The STERIS plc shares were sold for -0.5% lower than average price of previous purchases. This resulted in an overall loss of USD 170 The average price that the ETF previously sold STE share for is USD so the ETF has sold 162 shares on 2025-02-28 at a higher price than the previous selling average. |
| WAT - Waters Corporation | SELL | -96 @ USD 377.34 | USD -36,225 | The ETF sold 96 shares of WAT on 2025-02-28. The shares were previously bought for an average price of USD 377.41. The Waters Corporation shares were sold for 0.0% lower than average price of previous purchases. This resulted in an overall loss of USD 7 The average price that the ETF previously sold WAT share for is USD so the ETF has sold 96 shares on 2025-02-28 at a higher price than the previous selling average. |
| WAT - MULETFWATIMETFP | SELL | -96 @ USD 377.34 | USD -36,225 | The ETF sold 96 shares of WAT on 2025-02-28. The shares were previously bought for an average price of USD 377.41. The MULETFWATIMETFP shares were sold for 0.0% lower than average price of previous purchases. This resulted in an overall loss of USD 7 The average price that the ETF previously sold WAT share for is USD so the ETF has sold 96 shares on 2025-02-28 at a higher price than the previous selling average. |
| MTD - Mettler-Toledo International Inc | SELL | -33 @ USD 1272.72 | USD -42,000 | The ETF sold 33 shares of MTD on 2025-02-28. The shares were previously bought for an average price of USD 1284.47. The Mettler-Toledo International Inc shares were sold for -0.9% lower than average price of previous purchases. This resulted in an overall loss of USD 388 The average price that the ETF previously sold MTD share for is USD so the ETF has sold 33 shares on 2025-02-28 at a higher price than the previous selling average. |
| MTD - AMUNDI EUR GOV 710 | SELL | -33 @ USD 1272.72 | USD -42,000 | The ETF sold 33 shares of MTD on 2025-02-28. The shares were previously bought for an average price of USD 1284.47. The AMUNDI EUR GOV 710 shares were sold for -0.9% lower than average price of previous purchases. This resulted in an overall loss of USD 388 The average price that the ETF previously sold MTD share for is USD so the ETF has sold 33 shares on 2025-02-28 at a higher price than the previous selling average. |
| CNC - Concurrent Technologies Plc | SELL | -831 @ USD 58.16 | USD -48,331 | The ETF sold 831 shares of CNC on 2025-02-28. The shares were previously bought for an average price of USD 60.3127. The Concurrent Technologies Plc shares were sold for -3.6% lower than average price of previous purchases. This resulted in an overall loss of USD 1,789 The average price that the ETF previously sold CNC share for is USD so the ETF has sold 831 shares on 2025-02-28 at a higher price than the previous selling average. |
| CAH - Cardinal Health Inc | SELL | -396 @ USD 129.48 | USD -51,274 | The ETF sold 396 shares of CAH on 2025-02-28. The shares were previously bought for an average price of USD 123.777. The Cardinal Health Inc shares were sold for 4.6% higher than average price of previous purchases. This sale made a profit of USD 2,258 The average price that the ETF previously sold CAH share for is USD so the ETF has sold 396 shares on 2025-02-28 at a higher price than the previous selling average. |
| IQV - IQVIA Holdings Inc | SELL | -282 @ USD 188.8 | USD -53,242 | The ETF sold 282 shares of IQV on 2025-02-28. The shares were previously bought for an average price of USD 201.304. The IQVIA Holdings Inc shares were sold for -6.2% lower than average price of previous purchases. This resulted in an overall loss of USD 3,526 The average price that the ETF previously sold IQV share for is USD so the ETF has sold 282 shares on 2025-02-28 at a higher price than the previous selling average. |
| HUM - Hummingbird Resources PLC | SELL | -198 @ USD 270.42 | USD -53,543 | The ETF sold 198 shares of HUM on 2025-02-28. The shares were previously bought for an average price of USD 274.545. The Hummingbird Resources PLC shares were sold for -1.5% lower than average price of previous purchases. This resulted in an overall loss of USD 817 The average price that the ETF previously sold HUM share for is USD so the ETF has sold 198 shares on 2025-02-28 at a higher price than the previous selling average. |
| HUM - Humana Inc | SELL | -198 @ USD 270.42 | USD -53,543 | The ETF sold 198 shares of HUM on 2025-02-28. The shares were previously bought for an average price of USD 274.545. The Humana Inc shares were sold for -1.5% lower than average price of previous purchases. This resulted in an overall loss of USD 817 The average price that the ETF previously sold HUM share for is USD so the ETF has sold 198 shares on 2025-02-28 at a higher price than the previous selling average. |
| RMD - ResMed Inc | SELL | -240 @ USD 233.52 | USD -56,045 | The ETF sold 240 shares of RMD on 2025-02-28. The shares were previously bought for an average price of USD 241.128. The ResMed Inc shares were sold for -3.2% lower than average price of previous purchases. This resulted in an overall loss of USD 1,826 The average price that the ETF previously sold RMD share for is USD so the ETF has sold 240 shares on 2025-02-28 at a higher price than the previous selling average. |
| DXCM - DexCom Inc | SELL | -642 @ USD 88.37 | USD -56,734 | The ETF sold 642 shares of DXCM on 2025-02-28. The shares were previously bought for an average price of USD 82.0794. The DexCom Inc shares were sold for 7.7% higher than average price of previous purchases. This sale made a profit of USD 4,039 The average price that the ETF previously sold DXCM share for is USD so the ETF has sold 642 shares on 2025-02-28 at a higher price than the previous selling average. |
| IDXX - IDEXX Laboratories Inc | SELL | -132 @ USD 437.11 | USD -57,699 | The ETF sold 132 shares of IDXX on 2025-02-28. The shares were previously bought for an average price of USD 444.606. The IDEXX Laboratories Inc shares were sold for -1.7% lower than average price of previous purchases. This resulted in an overall loss of USD 989 The average price that the ETF previously sold IDXX share for is USD so the ETF has sold 132 shares on 2025-02-28 at a higher price than the previous selling average. |
| A - Agilent Technologies Inc | SELL | -471 @ USD 127.92 | USD -60,250 | The ETF sold 471 shares of A on 2025-02-28. The shares were previously bought for an average price of USD 136.968. The Agilent Technologies Inc shares were sold for -6.6% lower than average price of previous purchases. This resulted in an overall loss of USD 4,262 The average price that the ETF previously sold A share for is USD so the ETF has sold 471 shares on 2025-02-28 at a higher price than the previous selling average. |
| GEHC - GE HealthCare Technologies Inc. | SELL | -744 @ USD 87.35 | USD -64,988 | The ETF sold 744 shares of GEHC on 2025-02-28. The shares were previously bought for an average price of USD 88.6034. The GE HealthCare Technologies Inc. shares were sold for -1.4% lower than average price of previous purchases. This resulted in an overall loss of USD 933 The average price that the ETF previously sold GEHC share for is USD so the ETF has sold 744 shares on 2025-02-28 at a higher price than the previous selling average. |
| EW - Edwards Lifesciences Corp | SELL | -969 @ USD 71.62 | USD -69,400 | The ETF sold 969 shares of EW on 2025-02-28. The shares were previously bought for an average price of USD 71.0329. The Edwards Lifesciences Corp shares were sold for 0.8% higher than average price of previous purchases. This sale made a profit of USD 569 The average price that the ETF previously sold EW share for is USD so the ETF has sold 969 shares on 2025-02-28 at a higher price than the previous selling average. |
| COR - Cencora Inc. | SELL | -288 @ USD 253.54 | USD -73,020 | The ETF sold 288 shares of COR on 2025-02-28. The shares were previously bought for an average price of USD 245.681. The Cencora Inc. shares were sold for 3.2% higher than average price of previous purchases. This sale made a profit of USD 2,263 The average price that the ETF previously sold COR share for is USD so the ETF has sold 288 shares on 2025-02-28 at a higher price than the previous selling average. |
| HCA - HCA Holdings Inc | SELL | -297 @ USD 306.3 | USD -90,971 | The ETF sold 297 shares of HCA on 2025-02-28. The shares were previously bought for an average price of USD 335.202. The HCA Holdings Inc shares were sold for -8.6% lower than average price of previous purchases. This resulted in an overall loss of USD 8,584 The average price that the ETF previously sold HCA share for is USD so the ETF has sold 297 shares on 2025-02-28 at a higher price than the previous selling average. |
| BDX - Becton Dickinson and Company | SELL | -471 @ USD 225.53 | USD -106,225 | The ETF sold 471 shares of BDX on 2025-02-28. The shares were previously bought for an average price of USD 232.228. The Becton Dickinson and Company shares were sold for -2.9% lower than average price of previous purchases. This resulted in an overall loss of USD 3,155 The average price that the ETF previously sold BDX share for is USD so the ETF has sold 471 shares on 2025-02-28 at a higher price than the previous selling average. |
| REGN - Regeneron Pharmaceuticals Inc | SELL | -171 @ USD 698.74 | USD -119,485 | The ETF sold 171 shares of REGN on 2025-02-28. The shares were previously bought for an average price of USD 744.901. The Regeneron Pharmaceuticals Inc shares were sold for -6.2% lower than average price of previous purchases. This resulted in an overall loss of USD 7,894 The average price that the ETF previously sold REGN share for is USD so the ETF has sold 171 shares on 2025-02-28 at a higher price than the previous selling average. |
| ZTS - Zoetis Inc | SELL | -735 @ USD 167.24 | USD -122,921 | The ETF sold 735 shares of ZTS on 2025-02-28. The shares were previously bought for an average price of USD 169.767. The Zoetis Inc shares were sold for -1.5% lower than average price of previous purchases. This resulted in an overall loss of USD 1,857 The average price that the ETF previously sold ZTS share for is USD so the ETF has sold 735 shares on 2025-02-28 at a higher price than the previous selling average. |
| MCK - McKesson Corporation | SELL | -204 @ USD 640.26 | USD -130,613 | The ETF sold 204 shares of MCK on 2025-02-28. The shares were previously bought for an average price of USD 597.855. The McKesson Corporation shares were sold for 7.1% higher than average price of previous purchases. This sale made a profit of USD 8,651 The average price that the ETF previously sold MCK share for is USD so the ETF has sold 204 shares on 2025-02-28 at a higher price than the previous selling average. |
| CVS - CVS Health Corp | SELL | -2,043 @ USD 65.72 | USD -134,266 | The ETF sold 2043 shares of CVS on 2025-02-28. The shares were previously bought for an average price of USD 59.7446. The CVS Health Corp shares were sold for 10.0% higher than average price of previous purchases. This sale made a profit of USD 12,208 The average price that the ETF previously sold CVS share for is USD so the ETF has sold 2043 shares on 2025-02-28 at a higher price than the previous selling average. |
| CI - Cigna Corp | SELL | -453 @ USD 308.85 | USD -139,909 | The ETF sold 453 shares of CI on 2025-02-28. The shares were previously bought for an average price of USD 310.563. The Cigna Corp shares were sold for -0.6% lower than average price of previous purchases. This resulted in an overall loss of USD 776 The average price that the ETF previously sold CI share for is USD so the ETF has sold 453 shares on 2025-02-28 at a higher price than the previous selling average. |
| ELV - Elevance Health Inc | SELL | -375 @ USD 396.88 | USD -148,830 | The ETF sold 375 shares of ELV on 2025-02-28. The shares were previously bought for an average price of USD 402.045. The Elevance Health Inc shares were sold for -1.3% lower than average price of previous purchases. This resulted in an overall loss of USD 1,937 The average price that the ETF previously sold ELV share for is USD so the ETF has sold 375 shares on 2025-02-28 at a higher price than the previous selling average. |
| ELV - Elevance Health Inc | SELL | -375 @ USD 396.88 | USD -148,830 | The ETF sold 375 shares of ELV on 2025-02-28. The shares were previously bought for an average price of USD 402.045. The Elevance Health Inc shares were sold for -1.3% lower than average price of previous purchases. This resulted in an overall loss of USD 1,937 The average price that the ETF previously sold ELV share for is USD so the ETF has sold 375 shares on 2025-02-28 at a higher price than the previous selling average. |
| MDT - Medtronic PLC | SELL | -2,088 @ USD 92.02 | USD -192,138 | The ETF sold 2088 shares of MDT on 2025-02-28. The shares were previously bought for an average price of USD 88.8617. The Medtronic PLC shares were sold for 3.6% higher than average price of previous purchases. This sale made a profit of USD 6,595 The average price that the ETF previously sold MDT share for is USD so the ETF has sold 2088 shares on 2025-02-28 at a higher price than the previous selling average. |
| BMY - Bloomsbury Publishing Plc | SELL | -3,300 @ USD 59.62 | USD -196,746 | The ETF sold 3300 shares of BMY on 2025-02-28. The shares were previously bought for an average price of USD 57.1729. The Bloomsbury Publishing Plc shares were sold for 4.3% higher than average price of previous purchases. This sale made a profit of USD 8,075 The average price that the ETF previously sold BMY share for is USD so the ETF has sold 3300 shares on 2025-02-28 at a higher price than the previous selling average. |
| VRTX - Vertex Pharmaceuticals Inc | SELL | -417 @ USD 479.79 | USD -200,072 | The ETF sold 417 shares of VRTX on 2025-02-28. The shares were previously bought for an average price of USD 470.493. The Vertex Pharmaceuticals Inc shares were sold for 2.0% higher than average price of previous purchases. This sale made a profit of USD 3,877 The average price that the ETF previously sold VRTX share for is USD so the ETF has sold 417 shares on 2025-02-28 at a higher price than the previous selling average. |
| SYK - Stryker Corporation | SELL | -555 @ USD 386.19 | USD -214,335 | The ETF sold 555 shares of SYK on 2025-02-28. The shares were previously bought for an average price of USD 384.505. The Stryker Corporation shares were sold for 0.4% higher than average price of previous purchases. This sale made a profit of USD 935 The average price that the ETF previously sold SYK share for is USD so the ETF has sold 555 shares on 2025-02-28 at a higher price than the previous selling average. |
| DHR - Danaher Corporation | SELL | -1,044 @ USD 207.76 | USD -216,901 | The ETF sold 1044 shares of DHR on 2025-02-28. The shares were previously bought for an average price of USD 224.702. The Danaher Corporation shares were sold for -7.5% lower than average price of previous purchases. This resulted in an overall loss of USD 17,687 The average price that the ETF previously sold DHR share for is USD so the ETF has sold 1044 shares on 2025-02-28 at a higher price than the previous selling average. |
| DHR - Danaher Corporation | SELL | -1,044 @ USD 207.76 | USD -216,901 | The ETF sold 1044 shares of DHR on 2025-02-28. The shares were previously bought for an average price of USD 224.702. The Danaher Corporation shares were sold for -7.5% lower than average price of previous purchases. This resulted in an overall loss of USD 17,687 The average price that the ETF previously sold DHR share for is USD so the ETF has sold 1044 shares on 2025-02-28 at a higher price than the previous selling average. |
| GILD - Guild Esports Plc | SELL | -2,025 @ USD 114.31 | USD -231,478 | The ETF sold 2025 shares of GILD on 2025-02-28. The shares were previously bought for an average price of USD 99.8551. The Guild Esports Plc shares were sold for 14.5% higher than average price of previous purchases. This sale made a profit of USD 29,271 The average price that the ETF previously sold GILD share for is USD so the ETF has sold 2025 shares on 2025-02-28 at a higher price than the previous selling average. |
| PFE - Pfizer Inc | SELL | -9,207 @ USD 26.43 | USD -243,341 | The ETF sold 9207 shares of PFE on 2025-02-28. The shares were previously bought for an average price of USD 26.2665. The Pfizer Inc shares were sold for 0.6% higher than average price of previous purchases. This sale made a profit of USD 1,505 The average price that the ETF previously sold PFE share for is USD so the ETF has sold 9207 shares on 2025-02-28 at a higher price than the previous selling average. |
| BSX - Boston Scientific Corporation | SELL | -2,391 @ USD 103.79 | USD -248,162 | The ETF sold 2391 shares of BSX on 2025-02-28. The shares were previously bought for an average price of USD 97.5177. The Boston Scientific Corporation shares were sold for 6.4% higher than average price of previous purchases. This sale made a profit of USD 14,997 The average price that the ETF previously sold BSX share for is USD so the ETF has sold 2391 shares on 2025-02-28 at a higher price than the previous selling average. |
| BSX - MULSTRXSSXIMETFP | SELL | -2,391 @ USD 103.79 | USD -248,162 | The ETF sold 2391 shares of BSX on 2025-02-28. The shares were previously bought for an average price of USD 97.5177. The MULSTRXSSXIMETFP shares were sold for 6.4% higher than average price of previous purchases. This sale made a profit of USD 14,997 The average price that the ETF previously sold BSX share for is USD so the ETF has sold 2391 shares on 2025-02-28 at a higher price than the previous selling average. |
| AMGN - Amgen Inc | SELL | -870 @ USD 308.06 | USD -268,012 | The ETF sold 870 shares of AMGN on 2025-02-28. The shares were previously bought for an average price of USD 300.982. The Amgen Inc shares were sold for 2.4% higher than average price of previous purchases. This sale made a profit of USD 6,158 The average price that the ETF previously sold AMGN share for is USD so the ETF has sold 870 shares on 2025-02-28 at a higher price than the previous selling average. |
| TMO - Time Out Group plc | SELL | -618 @ USD 528.96 | USD -326,897 | The ETF sold 618 shares of TMO on 2025-02-28. The shares were previously bought for an average price of USD 544.598. The Time Out Group plc shares were sold for -2.9% lower than average price of previous purchases. This resulted in an overall loss of USD 9,664 The average price that the ETF previously sold TMO share for is USD so the ETF has sold 618 shares on 2025-02-28 at a higher price than the previous selling average. |
| ISRG - Intuitive Surgical Inc | SELL | -576 @ USD 573.15 | USD -330,134 | The ETF sold 576 shares of ISRG on 2025-02-28. The shares were previously bought for an average price of USD 568.447. The Intuitive Surgical Inc shares were sold for 0.8% higher than average price of previous purchases. This sale made a profit of USD 2,709 The average price that the ETF previously sold ISRG share for is USD so the ETF has sold 576 shares on 2025-02-28 at a higher price than the previous selling average. |
| MRK - Marks Electrical Group PLC | SELL | -4,101 @ USD 92.25 | USD -378,317 | The ETF sold 4101 shares of MRK on 2025-02-28. The shares were previously bought for an average price of USD 94.0642. The Marks Electrical Group PLC shares were sold for -1.9% lower than average price of previous purchases. This resulted in an overall loss of USD 7,440 The average price that the ETF previously sold MRK share for is USD so the ETF has sold 4101 shares on 2025-02-28 at a higher price than the previous selling average. |
| MRK - Merck & Company Inc | SELL | -4,101 @ USD 92.25 | USD -378,317 | The ETF sold 4101 shares of MRK on 2025-02-28. The shares were previously bought for an average price of USD 94.0642. The Merck & Company Inc shares were sold for -1.9% lower than average price of previous purchases. This resulted in an overall loss of USD 7,440 The average price that the ETF previously sold MRK share for is USD so the ETF has sold 4101 shares on 2025-02-28 at a higher price than the previous selling average. |
| ABT - Abbott Laboratories | SELL | -2,814 @ USD 138.01 | USD -388,360 | The ETF sold 2814 shares of ABT on 2025-02-28. The shares were previously bought for an average price of USD 125.126. The Abbott Laboratories shares were sold for 10.3% higher than average price of previous purchases. This sale made a profit of USD 36,256 The average price that the ETF previously sold ABT share for is USD so the ETF has sold 2814 shares on 2025-02-28 at a higher price than the previous selling average. |
| ABBV - AbbVie Inc | SELL | -2,862 @ USD 209.03 | USD -598,244 | The ETF sold 2862 shares of ABBV on 2025-02-28. The shares were previously bought for an average price of USD 187.054. The AbbVie Inc shares were sold for 11.7% higher than average price of previous purchases. This sale made a profit of USD 62,895 The average price that the ETF previously sold ABBV share for is USD so the ETF has sold 2862 shares on 2025-02-28 at a higher price than the previous selling average. |
| JNJ - Johnson & Johnson | SELL | -3,897 @ USD 165.02 | USD -643,083 | The ETF sold 3897 shares of JNJ on 2025-02-28. The shares were previously bought for an average price of USD 156.891. The Johnson & Johnson shares were sold for 5.2% higher than average price of previous purchases. This sale made a profit of USD 31,679 The average price that the ETF previously sold JNJ share for is USD so the ETF has sold 3897 shares on 2025-02-28 at a higher price than the previous selling average. |
| UNH - UnitedHealth Group Incorporated | SELL | -1,488 @ USD 474.96 | USD -706,740 | The ETF sold 1488 shares of UNH on 2025-02-28. The shares were previously bought for an average price of USD 542.751. The UnitedHealth Group Incorporated shares were sold for -12.5% lower than average price of previous purchases. This resulted in an overall loss of USD 100,873 The average price that the ETF previously sold UNH share for is USD so the ETF has sold 1488 shares on 2025-02-28 at a higher price than the previous selling average. |
| LLY - Eli Lilly and Company | SELL | -1,275 @ USD 920.63 | USD -1,173,803 | The ETF sold 1275 shares of LLY on 2025-02-28. The shares were previously bought for an average price of USD 842.665. The Eli Lilly and Company shares were sold for 9.3% higher than average price of previous purchases. This sale made a profit of USD 99,405 The average price that the ETF previously sold LLY share for is USD so the ETF has sold 1275 shares on 2025-02-28 at a higher price than the previous selling average. |